|
|
|
Stem Cell Related Patent Number US6495129
| Title: | Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3) | | Inventors: | Li, Haodong; Gaithersburg, MD, USA
Ruben, Steven M.; Olney, MD, USA | | Summary: | Described herein are methods of treating or preventing cytotoxic agent-induced damage to cells, via the administration of a myeloid progenitor inhibitor factor-1 polypeptide. The invention relates to therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine ?8 (CK?8 or ckb-8)), as well as the MPIF-1 polypeptide itself. Further disclosed are vectors, host cells and recombinant methods for their production. | | Abstract: | There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine .beta.8 (CK.beta.8 or ckb-8)), as well as MPIF-1 polypeptide itself, as are vectors, host cells and recombinant methods for producing the same. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6495129 | | Application Number: | US2000000689693 | | Date Filed: | 13/10/2000 | | Date Published: | 17/12/2002 | | Assignee: | Human Genome Sciences, Inc., Rockville, MD, USA |
|
|
